PBLS — PARABILIS MEDICINES INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 82 家机构在其最新 13F 申报中持有 PBLS(PARABILIS MEDICINES INC),合计申报市值 $2.78B,对应 102.19M 股。持仓集中度较高:前五大持有人占申报市值的 55.0%,前十大的集中度为 73.5%。
与上一季度相比,82 家新建仓位。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
PARABILIS MEDICINES INC(PBLS)的主要机构持有人包括 RA CAPITAL MANAGEMENT, L.P.、Fidelity Management & Research (FMR)、ARCH Venture Management, LLC,按 13F 申报市值在本页 124 家持有人中排名居前。
PBLS 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 77 | 36.15M | $1.15B | +9.3% |
| Q2 2026 | 82 | 102.19M | $2.78B | — |
表内 2 个季度中,机构持股合计减少 65%(Q2 2026 → Q3 2026)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 10.87M | $336.59M | 0.01% | 增持 | |
| 4.92M | $158.85M | 0.18% | 持有 | |
| 4.17M | $134.54M | 74.90% | 持有 | |
| 2.99M | $96.62M | 2.29% | 持有 | |
| 2.79M | $90.11M | 0.00% | 新进 | |
| 1.58M | $51.10M | 0.00% | 增持 | |
| 1.56M | $50.25M | 0.00% | 增持 | |
| 1.54M | $49.68M | 2.04% | 持有 | |
| 1.06M | $33.91M | 0.00% | 增持 | |
| 1.00M | $32.46M | 0.00% | 增持 | |
| 757.79K | $24.47M | 0.00% | 新进 | |
| 445.36K | $14.38M | 0.02% | 持有 | |
| 449.18K | $13.64M | 0.00% | 增持 | |
| 365.42K | $11.80M | 0.00% | 增持 | |
| 248.60K | $8.03M | 0.00% | 增持 | |
| 245.59K | $7.93M | 0.01% | 持有 | |
| 211.82K | $6.84M | 0.00% | 增持 | |
| 202.80K | $6.55M | 0.01% | 新进 | |
| 102.38K | $3.31M | 0.00% | 新进 | |
| 90.79K | $2.93M | 0.00% | 新进 | |
| 61.70K | $1.99M | 0.00% | 增持 | |
| 52.07K | $1.68M | 0.00% | 增持 | |
| 50.15K | $1.62M | 0.00% | 新进 | |
| 45.11K | $1.46M | 0.00% | 新进 | |
| 43.90K | $1.42M | 0.00% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
新建仓(Q2 2026)
- RA CAPITAL MANAGEMENT, L.P. 28.93M 股 · $791.91M
- Fidelity Management & Research (FMR) 10.29M 股 · $281.71M
- ARCH Venture Management, LLC 6.41M 股 · $175.52M
- venBio Partners LLC 5.27M 股 · $144.15M
- Alphabet Inc. 4.92M 股 · $134.65M
- Nextech Invest Ltd. 4.66M 股 · $127.63M
- Cormorant Asset Management, LP 4.62M 股 · $126.33M
- REGENERON PHARMACEUTICALS, INC. 4.17M 股 · $114.04M
- Siren, L.L.C. 2.99M 股 · $81.90M
- Farallon Capital Management 2.37M 股 · $64.82M
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.37M 股 · $64.82M
- Jupiter Topco LLC 2.30M 股 · $62.71M
完全清仓(较上季)
本季度没有被追踪基金完全清仓。
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 |
|---|---|---|
| Fidelity Management & Research (FMR) | 10.87M | 10.29M |
| Alphabet Inc. | 4.92M | 4.92M |
| REGENERON PHARMACEUTICALS, INC. | 4.17M | 4.17M |
| Siren, L.L.C. | 2.99M | 2.99M |
| BlackRock Inc | 2.79M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.58M | 1.30M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.56M | 1.16M |
| GENERAL ATLANTIC, L.P. | 1.54M | 1.54M |
| JPMorgan Chase & Co | 1.06M | 1.04M |
| Geode Capital Management | 1.00M | 99.36K |
| STATE STREET CORP | 757.79K | — |
| Marshall Wace | 445.36K | 445.36K |
| Franklin Resources | 449.18K | 381.49K |
| MFS Investment Management | 365.42K | 295.96K |
| VANGUARD FIDUCIARY TRUST CO | 248.60K | 27.80K |
| FEDERATED HERMES, INC. | 245.59K | 246.20K |
| UBS Group AG | 211.82K | 38.70K |
| Manulife Financial | 202.80K | — |
| BNY Mellon | 102.38K | — |
| Nuveen, LLC | 90.79K | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold PBLS?
As of 2026-Q2, 82 institutional funds reported holding PBLS (PARABILIS MEDICINES INC) in SEC 13F filings, with a combined reported value of $2.78B.
How many shares of PBLS do institutions own?
13F filers reported 102.19M shares of PBLS, worth $2.78B in aggregate at the end of 2026-Q2.
Is institutional ownership of PBLS rising or falling?
No prior-quarter baseline is available for a directional read.
Who are the top institutional holders of PBLS?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), ARCH Venture Management, LLC, Alphabet Inc., venBio Partners LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of PARABILIS MEDICINES INC?
The major shareholders of PARABILIS MEDICINES INC (PBLS) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., Fidelity Management & Research (FMR), ARCH Venture Management, LLC, Alphabet Inc., venBio Partners LLC, among 124 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.